Aprea Therapeutics Inc (APRE)
5.40
-0.19
(-3.40%)
USD |
NASDAQ |
May 17, 16:00
5.40
0.00 (0.00%)
Pre-Market: 20:00
Aprea Therapeutics Total Liabilities (Quarterly): 4.276M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.276M |
December 31, 2023 | 5.697M |
September 30, 2023 | 5.477M |
June 30, 2023 | 5.262M |
March 31, 2023 | 5.538M |
December 31, 2022 | 4.512M |
September 30, 2022 | 6.997M |
June 30, 2022 | 76.46M |
March 31, 2022 | 6.748M |
December 31, 2021 | 7.316M |
September 30, 2021 | 9.070M |
Date | Value |
---|---|
June 30, 2021 | 10.60M |
March 31, 2021 | 11.25M |
December 31, 2020 | 15.41M |
September 30, 2020 | 13.81M |
June 30, 2020 | 14.70M |
March 31, 2020 | 11.77M |
December 31, 2019 | 9.364M |
September 30, 2019 | 128.13M |
June 30, 2019 | 5.878M |
December 31, 2018 | 117.46M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.276M
Minimum
Mar 2024
128.13M
Maximum
Sep 2019
17.91M
Average
8.193M
Median
Total Liabilities (Quarterly) Benchmarks
NeuBase Therapeutics Inc | 9.485M |
Stoke Therapeutics Inc | 64.84M |
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 9.827M |
iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 33.20M |
Shareholders Equity (Quarterly) | 28.92M |